<< Back to Results
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Protocol Number:27018966IBS3002
-
Clinical Trial Categories
- Contact
- Annette Fudala, RMA, CRC at 215-355-9770
Location
- Feasterville Family Health Care Center N/A
1665 Bustleton Pike
Feasterville, PA 19053
